Ligan, Maria Faith .
HRN: 17-87-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/29/2024
METRONIDAZOLE 500MG (TAB)
02/29/2024
03/05/2024
PO
500mg
Q8
S/P Cs
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes